These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 467499)

  • 1. Dopamine receptor binding for agonists and antagonists in thermal exposed membranes.
    Lew JY; Goldstein M
    Eur J Pharmacol; 1979 May; 55(4):429-30. PubMed ID: 467499
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular regulatory mechanism of D2 dopamine receptor in the bovine striatum.
    Tanaka C; Kuno T; Shirakawa O; Saijoh K; Kubo N
    Adv Exp Med Biol; 1984; 175():75-84. PubMed ID: 6238508
    [No Abstract]   [Full Text] [Related]  

  • 3. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites.
    Coupet J; Rauh CE
    Eur J Pharmacol; 1979 Apr; 55(2):215-8. PubMed ID: 456420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S; Robson PA
    Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract]   [Full Text] [Related]  

  • 5. A partially rigid butyrophenone analog with extended conformation.
    Chan CC; Farmer PS
    Pharmazie; 1986 Dec; 41(12):835-6. PubMed ID: 2883672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of soluble dopamine D2-receptors from three species.
    Madras BK; Davis A; Seeman P
    Eur J Pharmacol; 1982 Mar; 78(4):431-8. PubMed ID: 7075677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptor binding: specificity, localization and regulation by ions and guanyl nucleotides.
    Creese I; Prosser T; Synder SH
    Life Sci; 1978 Aug; 23(5):495-9. PubMed ID: 692273
    [No Abstract]   [Full Text] [Related]  

  • 8. 3H-Domperidone: a selective ligand for dopamine receptors.
    Baudry M; Martres MP; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Sep; 308(3):231-7. PubMed ID: 503250
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of (3H)-terguride and (3H)-spiperone binding to dopamine receptors in the rat striatum.
    Valchár M; Dobrovský K; Krejcí I; Dlabac A
    Act Nerv Super (Praha); 1989 Apr; 31(1):77-9. PubMed ID: 2675526
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo [3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization.
    Chugani DC; Ackermann RF; Phelps ME
    J Cereb Blood Flow Metab; 1988 Jun; 8(3):291-303. PubMed ID: 2966803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the relative hydrophobicity and interaction with striatal dopamine receptors in the bull of representative dialkylaminoalkyl and dialkylaminoacyl phenothiazine derivatives].
    Brusova EG; Savel'eva MV
    Biull Eksp Biol Med; 1988 Aug; 106(8):163-5. PubMed ID: 2901277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilization and characterization of [3H]spiroperidol binding sites from subcellular fractions of the calf striatum.
    Clement-Cormier YC; Kendrick PE
    Biochem Pharmacol; 1980 Mar; 29(6):897-903. PubMed ID: 7387707
    [No Abstract]   [Full Text] [Related]  

  • 13. Demonstration of a complex subunit composition of a unitary dopamine receptor: effects of lesions and proteolytic enzymes on stereospecific binding.
    Leysen JE; Gommeren W; Van Gompel P
    Adv Biochem Psychopharmacol; 1983; 36():147-62. PubMed ID: 6858752
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine receptor binding is increased in diabetic rats.
    Lozovsky D; Saller CF; Kopin IJ
    Science; 1981 Nov; 214(4524):1031-3. PubMed ID: 6458088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor: isolation, purification, and regulation.
    Clement-Cormier YC
    Adv Biochem Psychopharmacol; 1980; 21():159-67. PubMed ID: 7376969
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine D2 receptor dissociation constant for spiperone: identical values using 3H-labeled agonist or 3H-labeled antagonist.
    Seeman P; Grigoriadis D
    Biochem Pharmacol; 1985 Nov; 34(22):4065-6. PubMed ID: 4062976
    [No Abstract]   [Full Text] [Related]  

  • 17. Solubilization of multiple binding sites for the dopamine receptor from calf striatal membranes.
    Clement-Cormier YC; Meyerson LR; McIsaac A
    Biochem Pharmacol; 1980 Jul; 29(14):2009-16. PubMed ID: 7406913
    [No Abstract]   [Full Text] [Related]  

  • 18. Early supersensitive changes in [3H] spiroperidol binding in the isolated striatum.
    Csernansky JG; Friedhoff AJ; Bonnet KA
    Biochem Biophys Res Commun; 1982 Mar; 105(1):117-20. PubMed ID: 6124243
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of pergolide with central dopaminergic receptors.
    Goldstein M; Lieberman A; Lew JY; Asano T; Rosenfeld MR; Makman MH
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3725-8. PubMed ID: 6932044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
    Seiler MP; Markstein R
    Mol Pharmacol; 1982 Sep; 22(2):281-9. PubMed ID: 7144729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.